There is a must-read investigatory article in the current Bloomberg Markets magazine on ethical issues at the industry review boards (IRBs) used in drug testing for big pharma. Provocative stuff, especially the human testing mill that exists in support of these companies:
“You get kind of desperate when you’re not in a study and start calling around,” Alvarez says. “You look at the calendar and figure it out. When you overlap, you find out how to do one at another clinic. It’s hard to stop.”
Related posts: